Sai Life Sciences
PublicSai Life Sciences is now publicly traded
The data on this page reflects Sai Life Sciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 18, 2024
Last Round
Private Equity
Jul 25, 2018
Est. Valuation at Exit
$311M
Total Funding Raised
$131.76M
Company Overview
Sai Life Sciences operates in Biotech and is based in Hyderabad, Telangana. Its recorded funding history includes a Private Equity round in July 2018.
Sai (Pharmaceuticals) is a healthcare services company that accelerates the discovery, development, and commercialization of new chemical entity small molecule programs through fully equipped facilities designed for quality and responsiveness, helping biotech and pharma clients achieve rapid development milestones and market launches.
Sector
Biotech
AI Layer
Non-AI
Sai Life Sciences Comparables
Compare Sai Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aragen Life Sciences | 89% | |
| BioDuro-Sundia | 84% | |
| Bellen Chemistry | 83% |
For institutional investors. Book with your work email.
Sai Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 18, 2024 | ||||
| Private Equity | Jul 25, 2018 | ||||
| VC Round | May 14, 2008 | ||||
| Secondary | Oct 27, 2007 |
For institutional investors. Book with your work email.
Sai Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | VC Round |
| Axis Asset Management Company | IPO |
| Ashoka WhiteOak Capital | IPO |
| Peak XV Partners | Secondary |
| Kotak Mahindra Mutual Fund | IPO |
| Morgan Stanley | IPO |
| Aditya Birla Sun Life AMC | IPO |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_earningsNov 6, 2026
Sai Life reports $8.88M in net profit for the September '26 quarter, compared with Rs 84 crore in the corresponding quarter last year, in India.
- has_earningsNov 6, 2026
Sai Life reports earnings of $10.4M, with net profit of Rs 98 crore in the September 2026 quarter compared with Rs 84 crore a year earlier, in India.
- has_earnings_increased_byNov 6, 2026
Sai Life reports net profit rising 17% year on year to Rs 98 crore for Q2FY27 in India on Nov 6th '26.
- recognized_asOct 30, 2026
Sai Life earns the Great Place To Work(R) certification for 2026-27 for the second time in India on Oct 19th '26, based on employee feedback about its workplace experiences and culture.
- partners_withOct 26, 2026
Sai Life and Liverpool sign an MoU to explore collaboration in scientific research, knowledge exchange, and talent development in India on Oct 26th '26.
For institutional investors. Book with your work email.
Sai Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.